Conference item
Once daily low-dose aspirin reduces urinary thromboxane B2 effectively even at 12-24 hours from dosing in the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial
- Publication status:
- Published
- Peer review status:
- Reviewed (other)
Actions
Access Document
- Files:
-
-
(Accepted manuscript, 284.2KB)
-
- Publisher copy:
- 10.1093/eurheartj/ehx502.P2088
Bibliographic Details
- Publisher:
- Oxford University Press Publisher's website
- Journal:
- European Heart Journal Journal website
- Volume:
- 38
- Issue:
- S1
- Article number:
- ehx502.P2088
- Publication date:
- 2017-08-29
- Acceptance date:
- 2017-04-19
- Event title:
- European Society of Cardiology Congress 2017
- DOI:
- EISSN:
-
1522-9645
- ISSN:
-
0195-668X
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
971654
- Local pid:
- pubs:971654
- Deposit date:
- 2021-11-18
Terms of use
- Copyright holder:
- Aung et al.
- Copyright date:
- 2017
- Rights statement:
- Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2017.
- Notes:
-
This is the accepted manuscript version of the article. The final version is available from Oxford University Press at https://doi.org/10.1093/eurheartj/ehx502.P2088
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record